OC-001

OC-001 · Ocellaris Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OC-001, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers [Phase 1, Phase 2]

See pricing